Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)
Multiple Cancer Types
The primary objective of this study now is to assess the anti-neoplastic activity of flotetuzumab in patients with PIF / ER AML, as determined by the proportion of patients who achieve complete remission (CR) or complete remission with partial hematologic recovery (CRh).
Leukemia,
Myelodysplastic Syndrome,
Phase I
I/II
Byrne, Michael
NCT02152956
VICCHEMP1828
Prospective, Randomized, Crossover Trial Comparing Recombinant von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women with von Willebrand Disease: The VWD Minimize Study
Multiple Cancer Types
Gynecologic,
Hematologic
III
Wheeler, Allison
NCT02606045
VICCNCBH1961
Prospective Observational Trial of an Absorbable Hydrogel Spacer in Prostate Cancer Radiotherapy
Prostate
Prostate
Prostate
N/A
Kirschner, Austin
VICCURO16112
